nifekalant hydrochloride has been researched along with Myocardial Infarction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisahara, M; Ikeuchi, M; Kozai, T; Kurisu, K; Onitsuka, H; Sekiya, M; Urabe, Y | 1 |
| Aonuma, K; Hiraoka, M; Hiroe, M; Igawa, M; Isobe, M; Okamoto, Y | 1 |
| Sugi, K | 1 |
| Fukuhara, S; Makino, K; Morimoto, A; Nakagawa, Y; Takase, E; Tateishi, E; Umeda, M; Yamamoto, K; Yokoyama, K | 1 |
| Hashimoto, H; Kondoh, K; Nakashima, M; Nishiyama, H; Ozaki, T; Uematsu, T; Umemura, K | 1 |
| Basler, GC; Black, SC; Chi, L; Friedrichs, GS; Gralinski, MR; Johnson, CR; Lucchesi, BR; Mu, DX; Pewitt, SR | 1 |
| Endo, M; Kasanuki, H; Koyanagi, H; Nishida, H; Ohnishi, S; Tomizawa, Y; Uwabe, K | 1 |
| Daikoku, S; Kamakura, S; Kurita, T; Miyazaki, S; Morii, I; Nonogi, H; Sutani, Y; Takenaka, K; Yasuda, S | 1 |
| Ando, S; Kasanuki, H; Matsuda, N; Shiga, T; Suzuki, T | 1 |
| Ishiwata, S; Iwase, T; Koizumi, T; Komiyama, N; Komuro, I; Momomura, S; Nakanishi, S; Nishiyama, S; Tanigawa, T | 1 |
1 review(s) available for nifekalant hydrochloride and Myocardial Infarction
| Article | Year |
|---|---|
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Electric Countershock; Humans; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Recurrence; Syndrome; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
1 trial(s) available for nifekalant hydrochloride and Myocardial Infarction
| Article | Year |
|---|---|
Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Procainamide; Pyrimidinones; Tachycardia, Ventricular | 2002 |
8 other study(ies) available for nifekalant hydrochloride and Myocardial Infarction
| Article | Year |
|---|---|
Nifekalant hydrochloride terminated electrical storms after coronary surgery.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Postoperative Complications; Pyrimidinones; Severity of Illness Index; Tachycardia, Ventricular; Treatment Outcome | 2010 |
[Despite medication, overdrive pacing is required to stabilize the electrical storm associated with acute coronary syndrome: a case report].
Topics: Acute Coronary Syndrome; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Resistance; Female; Humans; Myocardial Infarction; Pyrimidinones; Stents; Tachycardia, Ventricular; Treatment Outcome | 2007 |
Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Electrocardiography; Hemodynamics; Myocardial Infarction; Pyrimidinones; Refractory Period, Electrophysiological; Tachycardia, Ventricular | 1994 |
MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death.
Topics: Animals; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Death, Sudden, Cardiac; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Electrophysiology; Male; Myocardial Infarction; Pyrimidinones; Random Allocation; Ventricular Fibrillation | 1995 |
[The effect of MS-551 on two VT/Vf patients in CABG: a case report].
Topics: Aged; Angina, Unstable; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Coronary Artery Bypass; Humans; Intraoperative Care; Male; Middle Aged; Myocardial Infarction; Pyrimidinones | 1998 |
Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction.
Topics: Aged; Anti-Arrhythmia Agents; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Tachycardia; Ventricular Dysfunction | 2001 |
Reverse use-dependent QT prolongation during infusion of nifekalant in a case of recurrent ventricular tachycardia with old myocardial infarction.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Pyrimidinones; Tachycardia, Ventricular | 2001 |
Efficacy of nifekalant hydrochloride on the treatment of life-threatening ventricular tachyarrhythmias during reperfusion for acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Coronary Angiography; Electric Countershock; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pyrimidinones; Stents; Ventricular Fibrillation | 2001 |